Table 2.
Multivariate survival analysis of five-year overall and disease-free survival in 130 patients with hepatocellular carcinoma
Features | Five-year overall survival | Five-year disease-free survival | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |
Age | 1.132 | 0.316-3.516 | 0.192 | 1.536 | 0.322-3.736 | 0.125 |
Gender | 1.191 | 0.345-3.857 | 0.136 | 1.559 | 0.357-3.831 | 0.131 |
Serum AFP | 1.931 | 0.685-4.056 | 0.063 | 1.953 | 0.615-4.273 | 0.062 |
Tumor stage | 2.879 | 1.366-5.196 | 0.009 | 2.686 | 1.386-6.009 | 0.01 |
Tumor grade | 1.563 | 0.609-4.088 | 0.081 | 1.551 | 0.607-4.466 | 0.086 |
Presence of cirrhosis | 1.919 | 0.738-4.102 | 0.063 | 1.921 | 0.793-4.219 | 0.062 |
miR-149 expression | 3.938 | 1.472-8.038 | 0.003 | 3.608 | 1.431-7.686 | 0.006 |